Abstract
Nuclear cardiology utilizes radioactive tracers to image primarily physiology as opposed to anatomy. Its two key imaging techniques, single photon emission computed tomography (SPECT) and positron emission tomography (PET), offer tradeoffs in terms of availability, cost, artifacts, quantification, and complexity. This chapter discusses the physiologic signals of interest in nuclear cardiology, from their acquisition to processing to reproducibility and noise.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bassingthwaighte JB, Beard DA, Li Z. The mechanical and metabolic basis of myocardial blood flow heterogeneity. Basic Res Cardiol. 2001;96(6):582–594.
Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995;91(9):2435–2444.
Sokoloff L, Reivich M, Kennedy C, et al. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28(5):897–916.
Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, Bergmann SR, Brunken RC, Case J, Delbeke D, DiCarli MF, Garcia EV, Goldstein RA, Gropler RJ, Travin M, Patterson R, Schelbert HR; Quality Assurance Committee of the American Society of Nuclear Cardiology. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006;13(6):e121–e151.
Knuuti J, Schelbert HR, Bax JJ. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging. 2002;29(9):1257–1266.
Knuuti MJ, Nuutila P, Ruotsalainen U, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med. 1993;34(12):2068–2075.
Simon Cherry R, James Sorenson A, Michael Phelps E, eds. Physics in Nuclear Medicine. 3rd ed. Amsterdam: Elsevier; 2003.
Bateman TM, Berman DS, Heller GV, et al. American Society of Nuclear Cardiology position statement on electrocardiographic gating of myocardial perfusion SPECT scintigrams. J Nucl Cardiol. 1999;6(4):470–471.
Büther F, Dawood M, Stegger L, et al. List mode-driven cardiac and respiratory gating in PET. J Nucl Med. 2009;50(5):674–681.
Cho K, Kumiata S, Okada S, Kumazaki T. Development of respiratory gated myocardial SPECT system. J Nucl Cardiol. 1999;6(1 Pt 1):20–28.
Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey DL, Camici PG. Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging. 2006;33(5):584–588.
Kovalski G, Israel O, Keidar Z, Frenkel A, Sachs J, Azhari H. Correction of heart motion due to respiration in clinical myocardial perfusion SPECT scans using respiratory gating. J Nucl Med. 2007;48(4):630–636.
Dawood M, Büther F, Stegger L, et al. Optimal number of respiratory gates in positron emission tomography: a cardiac patient study. Med Phys. 2009;36(5):1775–1784.
Johnson NP, Gould KL. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1, 034 subjects. J Nucl Med. 2005;46(9):1427–1437.
Burkhoff D, Jones JW, Becker LC. Variability of myocardial perfusion defects assessed by thallium-201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery. J Am Coll Cardiol. 2001;38(4):1033–1039.
Prigent FM, Berman DS, Elashoff J, et al. Reproducibility of stress redistribution thallium-201 SPECT quantitative indexes of hypoperfused myocardium secondary to coronary artery disease. Am J Cardiol. 1992;70(15):1255–1263.
Mahmarian JJ, Moyé LA, Verani MS, Bloom MF, Pratt CM. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography. Am J Cardiol. 1995;75(16):1116–1119.
Alazraki NP, Krawczynska EG, DePuey EG, et al. Reproducibility of thallium-201 exercise SPECT studies. J Nucl Med. 1994;35(8):1237–1244.
Iskandrian AE, Garcia EV, Faber T. Analysis of serial images: a challenge and an opportunity. J Nucl Cardiol. 2008;15(1):23–26.
Garcia EV, DePuey EG, Sonnemaker RE, et al. Quantification of the reversibility of stress-induced thallium-201 myocardial perfusion defects: a multicenter trial using bull’s-eye polar maps and standard normal limits. J Nucl Med. 1990;31(11):1761–1765.
Van Train KF, Garcia EV, Maddahi J, et al. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med. 1994;35(4):609–618.
Van Train KF, Areeda J, Garcia EV, et al. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med. 1993;34(9):1494–1502.
Beller GA. Quantitative nuclear cardiology and future directions for SPECT imaging. J Nucl Cardiol. 2007;14(4):417–418.
Garcia EV, Faber TL, Cooke CD, Folks RD, Chen J, Santana C. The increasing role of quantification in clinical nuclear cardiology: the Emory approach. J Nucl Cardiol. 2007;14(4):420–432.
Germano G, Kavanagh PB, Slomka PJ, Van Kriekinge SD, Pollard G, Berman DS. Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach. J Nucl Cardiol. 2007;14(4):433–454.
Ficaro EP, Lee BC, Kritzman JN, Corbett JR. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14(4):455–465.
Watson DD, Smith WH 2nd. The role of quantitation in clinical nuclear cardiology: the University of Virginia approach. J Nucl Cardiol. 2007;14(4):466–482.
Liu YH. Quantification of nuclear cardiac images: the Yale approach. J Nucl Cardiol. 2007;14(4): 483–491.
Slomka PJ, Berman DS, Germano G. Quantification of serial changes in myocardial perfusion. J Nucl Med. 2004;45(12):1978–1980.
Itti E, Klein G, Rosso J, et al. Assessment of myocardial reperfusion after myocardial infarction using automatic 3-dimensional quantification and template matching. J Nucl Med. 2004;45(12):1981–1988.
Faber TL, Modersitzki J, Folks RD, Garcia EV. Detecting changes in serial myocardial perfusion SPECT: a simulation study. J Nucl Cardiol. 2005;12(3):302–310.
Sdringola S, Loghin C, Boccalandro F, Gould KL. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. J Nucl Med. 2006;47(1):59–67.
Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med. 1999;40(11):1848–1856.
Jagathesan R, Kaufmann PA, Rosen SD, et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med. 2005;46(2):212–219.
deKemp RA, Yoshinaga K, Beanlands RS. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol. 2007;14(3):380–397.
Takeda K, Saito K, Makino K, et al. Iodine-123-BMIPP myocardial washout and cardiac work during exercise in normal and ischemic hearts. J Nucl Med. 1997;38(4):559–563.
De Geeter F, Caveliers V, Pansar I, Bossuyt A, Franken PR. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. J Nucl Med. 1998;39(11):1850–1856.
Caveliers V, De Geeter F, Pansar I, Dendale P, Bossuyt A, Franken PR. Effect of exercise induced hyperlactatemia on the biodistribution and metabolism of iodine-123–15(p-iodophenyl)-3-R, S-methyl pentadecanoic acid in normal volunteers. Eur J Nucl Med. 2000; 27(1):33–40.
Nakajima K, Shimizu K, Taki J, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med. 1995;36(11):1934–1940.
Hashimoto A, Nakata T, Tsuchihashi K, Tanaka S, Fujimori K, Iimura O. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol. 1996;77(1):25–30.
Kim Y, Sawada Y, Fujiwara G, Chiba H, Nishimura T. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy: assessment by iodine-123 labelled 15-(p-iodophenyl)-3(R, S)-methylpentadecanoic acid myocardial single-photon emission tomography. Eur J Nucl Med. 1997;24(6):629–634.
Taki J, Nakajima K, Matsunari I, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med. 1997; 38(10):1503–1510.
Sakurabayashi T, Takaesu Y, Haginoshita S, et al. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol. 1999;19(4):480–484.
Kuwabara Y, Watanabe S, Nakaya J, et al. Postrevascularization recovery of fatty acid utilization in ischemic myocardium: a randomized clinical trial of potassium channel opener. J Nucl Cardiol. 2000;7(4):320–327.
Iwado Y, Mizushige K, Manabe K, et al. Suppression of fatty acid metabolism after exercise stress in patients with no electrocardiographic ST segment shift during balloon angioplasty. Angiology. 2001;52(12):841–849.
Inglese E, Leva L, Matheoud R, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med. 2007;48(10):1662–1669.
Teräs M, Tolvanen T, Johansson JJ, Williams JJ, Knuuti J. Performance of the new generation of whole-body PET/CT scanners: discovery STE and discovery VCT. Eur J Nucl Med Mol Imaging. 2007;34(10):1683–1692.
Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med. 2007;48(7):1112–1121.
Wollenweber SD, Gould KL. Investigation of cold contrast recovery as a function of acquisition and reconstruction parameters for 2D cardiac PET. IEEE Nucl Sci Symp Conf Rec. 5: 2552–2556;23-29 Oct 2005.
DICOM. http://medical.nema.org/; 2010 Accessed 06.10.2010.
Fred Mettler A Jr, Milton Guiberteau J, eds. Essentials of Nuclear Medicine Imaging. 5th ed. Amsterdam: Elsevier; 2006.
Ami Iskandrian E, Ernest Garcia V, eds. Nuclear Cardiac Imaging: Principles and Applications. 4th ed. New York: Oxford University; 2008.
van der Wall EE, eds. Noninvasive Imaging of Cardiac Metabolism. Dordrecht, The Netherlands: Martinus Nijhoff; 1987.
Paul Christian E, Kristen Waterstram-Rich M, eds. Nuclear Medicine and PET/CT: Technology and Techniques. 6th ed. Amsterdam: Elsevier; 2007.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Johnson, N.P., Leonard, S.M., Gould, K.L. (2010). Nuclear Cardiology: SPECT and PET. In: Goldberger, J., Ng, J. (eds) Practical Signal and Image Processing in Clinical Cardiology. Springer, London. https://doi.org/10.1007/978-1-84882-515-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-84882-515-4_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-514-7
Online ISBN: 978-1-84882-515-4
eBook Packages: MedicineMedicine (R0)